Skip to content

Clinical trials

Phase 3 Down Syndrome trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Down Syndrome Phase: Phase 3 Clear all

15 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20001
20021
20082
20101
20111
20121
20151
20191
20221
20231
20253
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed4
Recruiting4
Terminated4
Active, not recruiting2
Unknown status1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Children's Oncology Group2
Eisai Inc.2
New York State Institute for Basic Research2
Federal Research Institute of Pediatric Hematology, Oncology and Immunology1
Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau1
Institut Jerome Lejeune1
LuMind IDSC Foundation1
National Cancer Institute (NCI)1
Reprogenetics1
University of Colorado, Denver1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Down Syndrome15
Alzheimer Disease3
Cognitive Dysfunction3
Dementia2
Leukemia, Myeloid, Acute2
Precursor B-Cell Lymphoblastic Leukemia-Lymphoma2
Abortion, Spontaneous1
Burkitt Lymphoma1
Corneal Diseases1
Epilepsy1

Trials

Showing 51 to 15 of 15. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.